Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Liver Neoplasms × fludarabine phosphate × Clear all

Phase

Status

Recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 16 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Lymphocytic, Chronic, B-Cell 13 Lymphoma, Non-Hodgkin 10 Lymphoma 8 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Leukemia 7 Recurrence 6 Multiple Myeloma 6 Hodgkin Disease 6 Neoplasms 5 Myeloproliferative Disorders 5 Melanoma 5 Lymphoma, B-Cell 5 Leukemia, Biphenotypic, Acute 5 Lymphoma, Mantle-Cell 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Leukemia, Myelomonocytic, Juvenile 4 Immunoproliferative Disorders 4 Immune System Diseases 4 Precancerous Conditions 3 Neoplasm, Residual 3 Lymphoproliferative Disorders 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphatic Diseases 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Hematologic Neoplasms 3

Interventions

durvalumab 7 Bevacizumab 5 tremelimumab 3 Nivolumab 3 lenvatinib 2 fludarabine 2 Cyclophosphamide 2 zimberelimab 1 ropidoxuridine 1 relatlimab 1 pembrolizumab 1 fludarabine phosphate 1 atezolizumab 1 X-Rays 1 Whole Genome Sequencing 1 Technetium Tc 99m Aggregated Albumin 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Platinum 1 Photons 1 Paclitaxel 1 Observation 1 Long-Term Potentiation 1 Lidocaine 1 Immunotherapy 1 Immunoglobulin G 1 IMC-001 1 Hepatectomy 1 Gemcitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02932956 2025-09-19

GAP

Baylor College of Medicine

Phase 1 Active not recruiting

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡